Showing results (3181-3190 of 6,973) with videos related to

Sort By:
Pageof 698
Histopathology|June 14, 2012
Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 casesSeiichi Kato, Emiko Takahashi, Naoko Asano, et al.
Histopathology|June 14, 2012
Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndromeHeinke Pülhorn, Martin Herrmann, Harry Harms, et al.
Histopathology|March 8, 2012
Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissuesClaudia Schuster, Katharina Malinowsky, Sibylle Liebmann, et al.
Histopathology|March 8, 2012
Fallopian tube metastases of non-gynaecological origin: a series of 20 cases emphasizing patterns of involvement including intra-epithelial spreadColin J R Stewart, Yee C Leung, Ann Whitehouse
Histopathology|March 8, 2012
The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomasZarah Glad Zimling, Anne Jørgensen, Eric Santoni-Rugiu
Histopathology|March 8, 2012
Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localizationSebastian Huss, Eva Wardelmann, Diane Goltz, et al.
Histopathology|March 8, 2012
The presence and localization of onychodermis (specialized nail mesenchyme) containing onychofibroblasts in the nail unit: a morphological and immunohistochemical studyDong-Youn Lee, Ji-Hye Park, Hyun-Tae Shin, et al.
Histopathology|January 6, 2015
Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidneyJelena Mirkovic, Monica Calicchio, Christopher D Fletcher, et al.
Histopathology|January 6, 2015
Decreased expression of thymus-specific proteasome subunit β5t in Down syndrome patientsUtano Tomaru, Takahiro Tsuji, Shizuka Kiuchi, et al.
Histopathology|January 6, 2015
Tumour-to-tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation-specific antibodiesYuki Katsuya, Akihiko Yoshida, Shun-Ichi Watanabe, et al.
Pageof 698